Annovis Bio Announces New Data From Phase III Parkinson’s Study Highlighting Improvements in Unified Parkinson's Disease Rating Scale (Mds-Updrs) and Cognition After Treatment With Buntanetap
annovis bio宣佈來自III期帕金森病研究的新數據，突出了在使用buntanetap治療後統一帕金森病評分量表（MDS-UPDRS）和認知方面的改善。